Christopher G. Rowe

Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle

Richard L. Shimp, Christopher G. Rowe, Karine Reiter et al. · Vaccine · 2013 · 101 citations · Full text

Vaccination, Nanomedicine, Nanoparticles +8

The identification of markers segregating with resistance to <i>Schistosoma mansoni</i> infection in the snail <i>Biomphalaria glabrata</i>

Matty Knight, André Miller, Carolyn N. Patterson et al. · Proceedings of the National Academy of Sciences · 1999 · 67 citations

Parasitic Disease, Molecular Markers, Genetics +19

Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230

Puthupparampil V. Scaria, Christopher G. Rowe, Beth B. Chen et al. · npj Vaccines · 2019 · 51 citations · Full text

Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast

F. C. Thomas Allnutt, Robert M. Bowers, Christopher G. Rowe et al. · Vaccine · 2007 · 50 citations

Virus Structure, Molecular Virology, Pathogenesis +7

Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity

Puthupparampil V. Scaria, Beth Chen, Christopher G. Rowe et al. · PLoS ONE · 2017 · 39 citations · Full text